ClinicalTrials.gg
Enrolling by invitationNCT07786688LADYUpdated Aug 26, 2026

Prevalence of Childhood Maltreatment Among Women With Dysmenorrhea.

An interventional study of CTQ short version in Dysmenorrhea, sponsored by University Hospital, Clermont-Ferrand. Enrolling by invitation at 1 site in France. Open to female participants aged 18 Years to 53 Years. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
280
Allocation
Not applicable
Ages
18 Years to 53 Years
Sex
Female
01

Study summary

Dysmenorrhea is defined by the French National College of Gynecologists and Obstetricians as "cyclic abdominopelvic pain, occurring around menstruation, beginning shortly before its onset and sometimes persisting afterward." Its prevalence is difficult to determine precisely, but studies show that 16 to 90% of women in the general population experience permanent or occasional dysmenorrhea, and that more than 20% of them must limit their activities during menstruation. The origins of this pain remain poorly understood, but it is now known to be associated with significant emotional, psychological, and functional health consequences. Several studies have demonstrated that a history of violence experienced during childhood and adolescence is associated with the onset of chronic pain, but to the investigators' knowledge, no study has specifically analyzed the impact of violence on the presence of dysmenorrhea in adulthood. This study aims to administer a questionnaire assessing dysmenorrhea and history of violence (Childhood Trauma Questionnaire, short French version - CTQ) to patients consulting the Gynecology Department of Estaing University Hospital for menstrual pain (dysmenorrhea). The investigators aim to identify an association between the presence of dysmenorrhea and a history of violence during childhood.

Read the detailed description

The short version of the CTQ is a questionnaire comprising five subscales of maltreatment (emotional and physical neglect, sexual, physical, and emotional abuse), validated by several international studies and in the French-speaking population. The study will be offered to patients consulting the Gynecology Department of Estaing University Hospital for dysmenorrhea. An information sheet will be given to them at the end of the consultation. Participants will be contacted by phone within 48 business hours following the consultation to provide additional explanations about the study. These calls will be recorded in the patient's medical file. An email will then be sent containing a link to access the short version of the CTQ questionnaire, along with a consent form. By offering participants the opportunity to answer intimate questions outside the consultation setting, for example at home or in a place where they feel safe and comfortable, more authentic and relevant responses are expected. A reminder email will be sent to patients who have not responded to the online questionnaire on days 5, 10, and 15. Patients whose score corresponds to a history of maltreatment will be offered an appointment within a maximum of 15 days with a gynecologist specialized in victimology, in order to provide the care best suited to their needs (assessment, explanations, legal or psychological support procedures, referral to support associations, targeted gynecological follow-up). The patient will be contacted again 3 months later (in person or by phone) to assess treatment efficacy and satisfaction.

02

Conditions studied

  • Dysmenorrhea

Keywords

  • dysmenorrhea
  • chronic pain
  • children maltreatment
  • violence
03

In context

Dysmenorrhea

430 studies on the registry are indexed under Dysmenorrhea; 107 are open to participants now.

This study's planned enrollment of 280 is above the median of 62 across 363 interventional studies indexed under Dysmenorrhea.

Browse Dysmenorrhea studies →

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 859 studies on the registry; 179 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 53 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients consulting a gynecologist for dysmenorrhea, speaking and understanding French.
  • Patients affiliated to a social security system

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate
  • Inability to answer the questionnaire due to insufficient fluency in French
  • Minor patients (age \< 18)
  • Presence of cognitive disorders limiting the ability to complete the questionnaire
  • Patients with hysterectomy or adnexectomy
  • Patients under curators/guardianship/legal guardianship
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
280 participants (estimated)

Study arms

  • Other
    Children maltreatment

    We propose a medical appointment only to women who had suffered from children maltreatment

    Diagnostic Test: CTQ short version

Interventions

  • Diagnostic testCTQ short version

    We propose a medical appointment to all the women with a positive score at the CTQ short version

    Also known as: Appointment in a specific service

06

What researchers measure

Primary outcomes

  1. Prevalence of childhood abuse

    The prevalence (percentage) of childhood abuse in a population of women suffering from dysmenorrhea.

    Time frame: Day 15, at 3 months

Secondary outcomes

  1. Prevalence of different forms of violence during childhood

    The prevalence (percentage) of different forms of violence (sexual, physical or emotional) during childhood in a population of women suffering from dysmenorrhea

    Time frame: Day 15, at 3 months

  2. Type of Dysmenorrhea (Primary versus Secondary), by CTQ Status

    Classification of dysmenorrhea as primary (functional, in the absence of identifiable pelvic pathology) or secondary (organic, in the presence of a documented gynecological condition recorded in the medical file: endometriosis, adenomyosis, uterine fibroids, ovarian cyst, uterine malformation, history of salpingitis). The distribution between the two forms will be compared according to overall CTQ (Childhood Trauma Questionnaire) status and by domain of maltreatment.

    Time frame: 15 jours

  3. Type and Quantity of Analgesics Consumed by Patients, by CTQ Status

    Analgesic consumption recorded from the medical file, classified according to the WHO analgesic ladder (step I, II, or III), along with the maximum number of daily doses. The proportion of exposed patients will be compared according to overall CTQ (Childhood Trauma Questionnaire) status and by domain of maltreatment (emotional neglect, emotional abuse, physical neglect, physical abuse, sexual abuse).

    Time frame: Day 15

  4. Type of Contraceptive Method Used by Patients, by CTQ Status

    Contraceptive method recorded from the medical file (none, oral contraception, intrauterine device, implant, patch, vaginal ring, condoms, tubal ligation, vasectomy). The proportion of patients by contraceptive type will be compared according to overall CTQ (Childhood Trauma Questionnaire) status and by domain of maltreatment (emotional neglect, emotional abuse, physical neglect, physical abuse, sexual abuse)

    Time frame: Day 15

  5. Visual Analogue Scale (VAS) Score for Dysmenorrhea, by CTQ Status

    Intensity of menstrual pain assessed using a Visual Analogue Scale (VAS), scored from 0 (no pain) to 10 (worst pain imaginable). Mean VAS scores will be compared according to overall CTQ (Childhood Trauma Questionnaire) status and by domain of maltreatment (emotional neglect, emotional abuse, physical neglect, physical abuse, sexual abuse), as well as by the cumulative number of forms of childhood violence experienced.

    Time frame: Day 15

  6. Patient's satisfaction with the medical care

    3 months later, is the patient satisfied with the medical care proposed in victimology : YES or NO ?

    Time frame: At 3 months

07

Study locations

1 site
08

References and documents

Publications

  • Bernstein DP, Ahluvalia T, Pogge D, Handelsman L. Validity of the Childhood Trauma Questionnaire in an adolescent psychiatric population. J Am Acad Child Adolesc Psychiatry. 1997 Mar;36(3):340-8. doi: 10.1097/00004583-199703000-00012. PubMed 9055514 ↗
  • Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L, Medrano M, Desmond D, Zule W. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 2003 Feb;27(2):169-90. doi: 10.1016/s0145-2134(02)00541-0. PubMed 12615092 ↗
  • Paquette D, Laporte L, Bigras M, Zoccolillo M. [Validation of the French version of the CTQ and prevalence of the history of maltreatment]. Sante Ment Que. 2004 Spring;29(1):201-20. doi: 10.7202/008831ar. French. PubMed 15470573 ↗
  • Gordon JB. The importance of child abuse and neglect in adult medicine. Pharmacol Biochem Behav. 2021 Dec;211:173268. doi: 10.1016/j.pbb.2021.173268. Epub 2021 Sep 7. PubMed 34499948 ↗
  • Unnisa H, Annam P, Gubba NC, Begum A, Thatikonda K. Assessment of quality of life and effect of non-pharmacological management in dysmenorrhea. Ann Med Surg (Lond). 2022 Aug 30;81:104407. doi: 10.1016/j.amsu.2022.104407. eCollection 2022 Sep. PubMed 36147090 ↗
  • ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol. 2018 Dec;132(6):e249-e258. doi: 10.1097/AOG.0000000000002978. PubMed 30461694 ↗
  • Sachedina A, Todd N. Dysmenorrhea, Endometriosis and Chronic Pelvic Pain in Adolescents. J Clin Res Pediatr Endocrinol. 2020 Feb 6;12(Suppl 1):7-17. doi: 10.4274/jcrpe.galenos.2019.2019.S0217. PubMed 32041388 ↗
  • Moussaoui D, Grover SR. The Association between Childhood Adversity and Risk of Dysmenorrhea, Pelvic Pain, and Dyspareunia in Adolescents and Young Adults: A Systematic Review. J Pediatr Adolesc Gynecol. 2022 Oct;35(5):567-574. doi: 10.1016/j.jpag.2022.04.010. Epub 2022 May 13. PubMed 35569788 ↗
  • Liebschutz J, Battaglia T, Finley E, Averbuch T. Disclosing intimate partner violence to health care clinicians - what a difference the setting makes: a qualitative study. BMC Public Health. 2008 Jul 4;8:229. doi: 10.1186/1471-2458-8-229. PubMed 18601725 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Oct 2027, 38 months after the start.

Of 178 non-industry interventional studies with no phase under Dysmenorrhea, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 16. This study's planned 38 months is above that.

Counting every sponsor, half of 188 studies reached it within 8 months; a quarter within 3 and three quarters within 16.

How these figures are worked out, and which studies are left out of them.

Registered
May 14, 2024
First posted
Aug 26, 2026
StartActual
Jul 25, 2024
Primary completionEst.
Oct 1, 2027
CompletionEst.
Oct 1, 2027
Last update
Aug 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07786688
Responsible party
Sponsor
First posted
Aug 26, 2026
Start date
Jul 25, 2024
Primary completion
Oct 1, 2027 (estimated)
Completion
Oct 1, 2027 (estimated)
Last update
Aug 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion